KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Receivables - Net: 2018-2024

Historic Receivables - Net for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $41.7 million.

  • Adaptive Biotechnologies' Receivables - Net rose 9.82% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 9.82%. This contributed to the annual value of $41.7 million for FY2024, which is 9.91% up from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Receivables - Net of $41.7 million as of FY2024, which was up 9.91% from $38.0 million recorded in FY2023.
  • Adaptive Biotechnologies' 5-year Receivables - Net high stood at $41.7 million for FY2024, and its period low was $10.0 million during FY2020.
  • Over the past 3 years, Adaptive Biotechnologies' median Receivables - Net value was $40.1 million (recorded in 2022), while the average stood at $39.9 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first dropped by 20.74% in 2020, then soared by 130.09% in 2022.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Receivables - Net stood at $10.0 million in 2020, then soared by 73.28% to $17.4 million in 2021, then skyrocketed by 130.09% to $40.1 million in 2022, then declined by 5.21% to $38.0 million in 2023, then rose by 9.91% to $41.7 million in 2024.